CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 3.49: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
4.43%Above 5Y avg (2.91%)
Annual Rate
HKD 0.10Paid semi-annual
Payout Ratio
29.9%Sustainable
Last Ex-Dividend
Aug 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.39BHKD304.28M · vs all stocks (USD)
Trailing P/E
4.82xRevenue (TTM)
1.72BHKD219.50M · vs all stocks (USD)
Profit Margin
15.41%Beta
0.0120xvs all stocks
52-Week Change
-57.50%vs all stocks
Forward Annual Dividend Yield
4.43%vs all stocks
Market Capitalization
2.39BHKD304.28M · vs all stocks (USD)
Enterprise Value
823.25MHKD104.94M · vs all stocks (USD)
Trailing P/E
4.82xForward P/E
8.39xPEG Ratio
-0.0482xPrice to Sales (TTM)
0.7431xPrice to Book (MRQ)
0.5029xEnterprise to Revenue
0.4780xEnterprise to EBITDA
2.07xProfit Margin
15.41%Operating Margin
17.61%Return on Assets (TTM)
6.27%Return on Equity (TTM)
11.01%Revenue (TTM)
1.72BHKD219.50M · vs all stocks (USD)
Revenue per Share (TTM)
3.04HKDUpdated Sep 20, 2026Quarterly Revenue Growth
-10.50%Gross Profit (TTM)
1.50BHKD190.64M · vs all stocks (USD)
EBITDA (TTM)
492.99MHKD62.84M · vs all stocks (USD)
Net Income (TTM)
265.41MHKD33.83M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-32.20%Operating Cash Flow (TTM)
282.52MHKD36.01M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
142.05MHKD18.11M · vs all stocks (USD)
Forward Annual Dividend Rate
0.1000HKDUpdated Sep 20, 2026Forward Annual Dividend Yield
4.43%vs all stocks
Trailing Annual Dividend Rate
0.1200HKDUpdated Sep 20, 2026Trailing Annual Dividend Yield
5.32%vs all stocks
5-Year Average Dividend Yield
2.91%vs all stocks
Payout Ratio
29.91%Revenue
1.81BHKDFY2025 · Dec 31, 2025Cost of Goods Sold
195.92MHKDFY2025 · Dec 31, 2025Gross Profit
1.62BHKDFY2025 · Dec 31, 2025Operating Income
413.45MHKD52.70M · vs all stocks (USD)
Pre-tax Income
414.66MHKDFY2025 · Dec 31, 2025Income Tax Expense
96.57MHKDFY2025 · Dec 31, 2025Net Income
318.09MHKDFY2025 · Dec 31, 2025EBIT
422.48MHKDFY2025 · Dec 31, 2025EBITDA (Income Statement)
492.99MHKDFY2025 · Dec 31, 2025Selling, General & Administrative
1.21BHKDFY2025 · Dec 31, 2025Non-operating Interest Income
11.83MHKDFY2025 · Dec 31, 2025Non-operating Interest Expense
7.82MHKDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00HKDFY2025 · Dec 31, 2025Operating Cash Flow
302.98MHKDFY2025 · Dec 31, 2025Free Cash Flow
195.55MHKDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
782.73MHKDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
414.66MHKDFY2025 · Dec 31, 2025Other Non-cash Items
-6.51MHKDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-86.82MHKDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.35MHKDFY2025 · Dec 31, 2025Capital Expenditures
-107.43MHKDFY2025 · Dec 31, 2025Net Intangibles (CF)
-67.10MHKDFY2025 · Dec 31, 2025Net Acquisitions
-1.05MHKDFY2025 · Dec 31, 2025Sale of Investments
0.00HKDFY2025 · Dec 31, 2025Net Investing Cash Flow
-108.49MHKDFY2025 · Dec 31, 2025Long-term Debt Issuance
233.87MHKDFY2025 · Dec 31, 2025Long-term Debt Payments
-82.44MHKDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
0.00HKDFY2025 · Dec 31, 2025Common Stock Repurchase
-325.27KHKDFY2025 · Dec 31, 2025Common Dividends Paid
-73.71MHKDFY2025 · Dec 31, 2025Net Financing Cash Flow
77.40MHKDFY2025 · Dec 31, 2025Shares Outstanding
566.00MSharesUpdated Sep 20, 2026Float Shares
259.37MSharesUpdated Sep 20, 2026% Held by Insiders
54.28%vs all stocks
% Held by Institutions
1.11%vs all stocks
Total Cash (MRQ)
807.73MHKD102.96M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.43HKDUpdated Sep 20, 2026Total Debt (MRQ)
348.99MHKD44.49M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1369xCurrent Ratio (MRQ)
2.15xBook Value per Share (MRQ)
4.50HKDUpdated Sep 20, 2026Total Assets
3.49BHKD444.97M · vs all stocks (USD)
Total Current Assets
1.62BHKDFY2025 · Dec 31, 2025Total Liabilities
1.08BHKDFY2025 · Dec 31, 2025Total Non-current Assets
1.87BHKDFY2025 · Dec 31, 2025Total Non-current Liabilities
310.77MHKDFY2025 · Dec 31, 2025Total Current Liabilities
766.91MHKDFY2025 · Dec 31, 2025Cash
572.76MHKDFY2025 · Dec 31, 2025Cash Equivalents
209.97MHKDFY2025 · Dec 31, 2025Cash & Cash Equivalents
782.73MHKDFY2025 · Dec 31, 2025Other Short-term Investments
1.41MHKDFY2025 · Dec 31, 2025Accounts Receivable
656.55MHKDFY2025 · Dec 31, 2025Inventory
79.40MHKDFY2025 · Dec 31, 2025Accounts Payable
11.56MHKDFY2025 · Dec 31, 2025Short-term Debt
69.10MHKDFY2025 · Dec 31, 2025Long-term Debt
277.80MHKDFY2025 · Dec 31, 2025Common Stock (Book)
56.70MHKDFY2025 · Dec 31, 2025Retained Earnings
2.36BHKDFY2025 · Dec 31, 2025Total Shareholders' Equity
2.41BHKD307.60M · vs all stocks (USD)
52-Week Low
2.01HKDUpdated Sep 20, 202652-Week High
5.38HKDUpdated Sep 20, 202652-Week Change
-57.50%vs all stocks
Beta
0.0120xvs all stocks
50-Day MA
2.37HKDUpdated Sep 20, 2026200-Day MA
3.27HKDUpdated Sep 20, 2026Avg 10-Day Volume
270.85KSharesUpdated Sep 20, 2026Avg 30-Day Volume
312.67KSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.4700HKDUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.49: safe zoneNotable
Altman Z-Score: 3.49
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
EyePoint Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hikal Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lavipharm S.A.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Century Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
JBM
Tier 1ProductionApproval-Gated PipelineRuleFlow
AtaiBeckley Inc.
Tier 1ProductionApproval-Gated PipelineRule
Evommune, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Jilin Province Xidian Pharmaceutical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Abeona Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Anhui Huangshan Capsule Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Timee Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Beijing Xiaocheng Technology Co. Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Edan Instruments Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities